Companies / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Vanguard To Market Indian-Made Generics
August 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
US-based Vanguard Pharmaceutical has signed a contract to sell the generics portfolio of India's Arbro Pharmaceutical in Latin America and the Caribbean. The deal gives Vanguard exclusive rights to market Arbro's range of 150 generics in the region for 10 years. Vanguard is in the process of setting up operations in Brazil, Peru and Paraguay to enable it to compete in government tenders and set up a distribution network to penetrate the private sector.